Ovintiv Inc.
In the published model solve dated 2026-Q2, anchored at $57.89, Ovintiv Inc. (OVV) is priced for +10.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 27, 2026 from SEC EDGAR filings.
- The number that decides Ovintiv is free cash flow, not reported earnings. Q1 2026 generated $634 million of free cash flow even as the company booked a $630 million net loss on impairments. Cash is the real story; the loss is accounting. - Priced on mid-cycle earnings, the stock is reasonable. At $52.39 the market pays about 14x normalized operating income, implying roughly 8% annual operating growth for five years, a rate within what Ovintiv has delivered. - The transformation is the catalyst
Is OVV overvalued? See what's priced in →
590 institutional managers reported holding OVV in 13F filings for the quarter ended 2026-03-31. Together they hold about 91% of the company; the top 10 hold 51%. 122 opened new positions that quarter. Held by Vanguard Group, BlackRock, FMR (Fidelity), among others. On the short side, 12.9M shares were sold short as of the 2026-06-15 count, about 5% of shares outstanding (5 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
OVV's share count grew 2.7% over the past five years even with $2.24B spent on repurchases. It pays a dividend, and has paid one every year in our records (7 and counting); the current rate is $1.20 a share annually. Cash returned over the past three years: $873.00M in dividends and $1.09B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at OVV over the trailing three years: 2024: 1 buy totaling $79k. 16 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
OVV's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-28 | +4.7% | +5.4% |
| 2023-11-08 | -5.3% | -8.0% |
| 2024-02-28 | +4.1% | +6.0% |
| 2024-05-08 | -3.0% | -7.0% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
OVV's latest 8-K filings: 2026-07-23 (items 2.02, 8.01, 9.01); 2026-05-11 (items 2.02, 8.01, 9.01); 2026-05-08 (items 5.07, 9.01); 2026-04-09 (items 1.02, 2.01, 7.01, 8.01, 9.01); 2026-02-23 (items 2.02, 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.